The Role of Mycobiota During Immunomodulatory Therapy For Inflammatory Bowel Disease.

Exploring the Interaction of the IBD Virome With Innate Immune Sensors, RIG-I And MDA-5.

Massively Parallel Single Cell Transcriptomics to Define Microbial-Regulated Host Circuits That Influence Colonic Inflammation.

Engineering Probiotic Organisms to Sense, Diagnose, and Treat Inflammation.

Capitalizing on Galectin-1-Glycan Interactions for the Design of Novel Therapeutic Strategies in Inflammatory Bowel Diseases.

Prospective Double-Blind Diet Controlled Trial of Low Carbohydrate Diets in Pediatric Crohn’s Disease.

The Impact of Fermentable Carbohydrate Restriction (Low FODMAP Diet) on Functional Gut Symptoms, Gut Microbiota and Immunology in Patients With Crohn’s Disease.

Exploring The Therapeutic Potential Of MUC2, A Gut-Specific Mucin With Anti-Inflammatory Properties.

Targeting Calpain-Induced Cleavage Of HMGB1 Client Proteins To Restore Intestinal And Metabolic Homeostasis In Inflammatory Bowel Diseases.

Novel Adhesive Interactions Modulate T Cell Responses In IBD.